References
- Fox RK. Hepatitis C virus outside the liver. Curr Hepatitis Rep 2003; 2: 116–24
- Quecedo L, Costa J, Enriquez de SR. Role of hepatitis C virus in porphyria cutanea tarda hepatopathy. Med Clin (Barc) 1996; 106: 321–4
- Tsukazaki N, Watanabe M, Irifune H. Porphyria cutanea tarda and hepatitis C virus infection. Br J Dermatol 1998; 138: 1015–7
- Bygum A, Christiansen L, Petersen NE, Horder M, Thomsen K, Brandrup F. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status. Acta Derm Venereol 2003; 83: 115–20
- Salmon P, Oakley A, Rademaker M, Duffill M. Hepatitis C virus infection and porphyria cutanea tarda in Australasia. Arch Dermatol 1996; 132: 91
- Stolzel U, Kostler E, Koszka C, Stoffler-Meilicke M, Schuppan D, Somasundaram R, et al. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 1995; 21: 1500–3
- Lai FM, Tam JS, Liew CT, Ip M, Lai KN. Low prevalence of hepatitis C virus antibodies with primary membranous nephropathy and membranoproliferative glomerulonephritis in Hong Kong. Nephron 1995; 70: 367–8
- Rostoker G, Deforges L, Ben MA, Remy P, Lang P, Duval JR, et al. Low prevalence of antibodies to hepatitis C virus among adult patients with idiopathic membranoproliferative type I glomerulonephritis in France. Nephron 1995; 69: 97
- Yamabe H, Johnson RJ, Gretch DR, Fukushi K, Osawa H, Miyata M, et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995; 6: 220–3
- Kristiansen MG, Gutteberg T, Berg LK, Sjursen H, Mortensen L, Florholmen J. Hepatitis C in northern Norway. Tidsskr Nor Lægeforen 2002; 122: 1974–6
- Kristiansen MG, Løchen M-L, Gutteberg T, Berg LK, Mortensen L, Eriksen BO, et al. Long-term morbidity and mortality of community-acquired hepatitis C positive patients in Northern Norway. Gut 2006; 55 Suppl V: A150
- Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, et al. Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheumatism 1999; 42: 2204–12
- Forns X, Ampurdanes S, Sanchez-Tapias JM, Guilera M, Sans M, Sanchez-Fueyo A, et al. Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center. J Hepatol 2001; 35: 265–71
- Berk DR, Mallory SB, Keeffe EB, Ahmed A. Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy. Clin Gastroenterol Hepatol 2007; 5: 142–51
- Fabritzi F, Bruchfeld A, Mangano S, Dixit V, Messa P, Martin P. Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials. Int J Artif Organs 2007; 30: 212–9